CURRENTLY ONLY ENROLLING GLIOBLASTOMA PATIENTS AT FIRST RECURRENCE

Clinical trials for CURRENTLY ONLY ENROLLING GLIOBLASTOMA PATIENTS AT FIRST RECURRENCE explained in plain language.

Never miss a new study

Get alerted when new CURRENTLY ONLY ENROLLING GLIOBLASTOMA PATIENTS AT FIRST RECURRENCE trials appear

Sign up with your email to follow new studies for CURRENTLY ONLY ENROLLING GLIOBLASTOMA PATIENTS AT FIRST RECURRENCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Scientists test 'Trojan Horse' stem cells to fight deadly brain cancer

Disease control Terminated

This early-stage study is testing the safety of a new treatment for aggressive brain tumors that have returned. Doctors use specially engineered neural stem cells designed to seek out cancer cells and deliver a virus that kills them. The treatment is given directly into the brain…

Matched conditions: CURRENTLY ONLY ENROLLING GLIOBLASTOMA PATIENTS AT FIRST RECURRENCE

Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

CURRENTLY ONLY ENROLLING GLIOBLASTOMA PATIENTS AT FIRST RECURRENCE

Get alerted when new CURRENTLY ONLY ENROLLING GLIOBLASTOMA PATIENTS AT FIRST RECURRENCE trials appear

Scientists test 'Trojan Horse' stem cells to fight deadly brain cancer